Skip to main content

Plant Platform for Therapeutic Monoclonal Antibody Production

  • Chapter
  • First Online:
Plant Biotechnology: Progress in Genomic Era

Abstract

Plant cells have protein synthesis and post-translational modification (glycosylation and phosphorylation) mechanisms similar to those of animal cells therefore the development of biotechnology allows considering plants as factories for therapeutic proteins, including therapeutic monoclonal antibodies (TMAs). The plant monoclonal antibody production platform has attracted researchers’ attention due to its flexibility, speed, scalability, low production costs, and absence of a risk of contamination by pathogens of animal origin. Modern methods for the production of therapeutic proteins are based on stably transformed transgenic plants and the transient expression of foreign genes. This chapter considers modern methods for obtaining TMAs produced in plants (P-TMA), features of the carbohydrate composition and methods for humanising the carbohydrate profile of P-TMAs. Examples of P-TMAs that have successfully passed preclinical trials and have a perspective in clinical use are given. The prospects of P-TMAs are determined by the economic benefits and speed of production, which are especially important for individualised cancer therapy, as well as cases of bioterrorism and pandemics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuri L. Dorokhov .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dorokhov, Y.L., Sheshukova, E.V., Komarova, T.V. (2019). Plant Platform for Therapeutic Monoclonal Antibody Production. In: Khurana, S., Gaur, R. (eds) Plant Biotechnology: Progress in Genomic Era. Springer, Singapore. https://doi.org/10.1007/978-981-13-8499-8_24

Download citation

Publish with us

Policies and ethics